GenScript Received OLAW (Office of Laboratory Animal Welfare) Approval for Animal Welfare Assurance
Summary
“This credential will greatly facilitate the antibody and animal services to our customers,” commented Dr. Nick YAN, Vice President of GenScript.The OLAW provides guidance and interpretation of the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals.Headquartered in Piscataway, New Jersey, GenScript is the largest gene synthesis supplier in the USA, with subsidiaries in France, Japan, and China.### For further information, please contact: Sally Wang Executive Vice President GenScript USA Inc. 1-(732) 885-9188 Source: www.genscript.com Piscataway, NJ, November 24, 2010 --( PR.com )-- Internationally recognized biology contract research organization GenScript USA Inc. received the approval of Animal Welfare Assurance from the Office of Laboratory Animal Welfare (OLAW) of the U.S. National Institutes of Health (NIH) for its animal facility on 9 Nov, 2010.“Our purpose of having Animal Welfare Assurance is to reinforce our principle on laboratory animal welfare, so that we can provide quality services to our clients,” commented Mr. Liang CAO, Manager of Animal Model Department.The OLAW provides guidance and interpretation of the Public Health Service (PHS) Policy on Humane Care and Use of Laboratory Animals.GenScript is a contract research organization (CRO) specialized in biological research and early-phase drug discovery services.